Tilray discloses $1.2B quarterly loss, plan to buy cannabis rival Hexo for $56M

Canadian cannabis producer Tilray Brands reported a net loss of $1.2 billion (1.5 billion Canadian dollars) for its quarter ended in February and said it agreed to buy troubled rival Hexo Corp. for $56 million.

According to a news release, Canada- and U.S.-based Tilray attributed the quarterly red ink to its declining market capitalization and a net asset reduction resulting from higher interest rates.


The company, which has offices in Leamington, Ontario, and New York, also booked an inventory valuation write-down worth $55 million.

Tilray said the steep loss has no impact on the company’s compliance with debt covenants, its cash flows or available liquidity.

Sales for the December-February quarter missed analysts’ expectations, coming in at $145.6 million, down from $151.9 million one year earlier.

Cannabis appeared to be a drag on the company’s revenue, with sales from its marijuana business falling to $47.5 million for the

Read full article on Marijuana Business Daily

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *